Recurrent High Grade Glioma Treated by LITT

NARecruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

March 19, 2026

Study Completion Date

September 19, 2027

Conditions
Recurrent High Grade Glioma
Interventions
DEVICE

LITT

The patients in the intervention group will receive LITT, other treatments, including systematic therapy and radiology therapy, would be not restricted except the craniotomy of resection before tumor progression or emergency. The patient is supposed to receive LITT post-randomization within 7 days.

OTHER

Control

The patients in the control group will receive the best medical management under guidelines except LITT before tumor progression. Craniotomy will not be restricted,

Trial Locations (9)

Unknown

RECRUITING

Beijing Tiantan Hospital, Beijing

NOT_YET_RECRUITING

Beijing Tsinghua Changgung Hospital, Beijing

RECRUITING

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Tongji Hospital, Wuhan

RECRUITING

The First Hospital of Jilin University, Changchun

RECRUITING

The Peoples Hospital of Liaoning, Shenyang

RECRUITING

Qilu Hospital, Jinan

RECRUITING

Huashan Hospital, Shanghai

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER